Arbutus Biopharma Corporation (ABUS)

[MinnieM]

New Ebola treatment effective three days after infection
http://www.sciencedaily.com/releases/2015/04/150422135748.htm

Summary:A post-exposure treatment that is effective against a specific strain of the Ebola virus that killed thousands of people in West Africa has been developed by researchers. The treatment uses a sequence specific short strand of RNA, known as siRNA, designed to target and interfere with the Ebola virus, rendering it harmless. One of the advantages of this approach is the ability to quickly modify it to different viral strains.

The Tekmira siRNA-based therapeutic is now being evaluated in Ebola-infected patients in Sierra Leone.

Tekmira and Collaborators Publish Positive Preclinical Ebola Survival Data in Nature Journal
http://www.marketwatch.com/story/tekmira-and-collaborators-publish-positive-preclinical-ebola-survival-data-in-nature-journal-2015-04-22







In Reply to 'Echo20'
Nano patent

The Africa Ebola testing should be. ready for
Showing.

Echo20